Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131.

Source:http://linkedlifedata.com/resource/pubmed/id/18779504

Download in:

View as

General Info

PMID
18779504